TMDX Filing
4Filing Date: Jul 14, 2026

TransMedics Group, Inc. (TMDX) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001193125-26-303704open_in_new
Total Value$0
Trades3
Insiders1

Transaction Details

Hassanein Waleed H
President & CEO, Director·Direct
Grant · Acquire
Common Stock
Shares+49.67K
Price$0.00
Total Value$0
Shares Owned After171.09K
Transaction DateJul 10, 2026
Footnotes ▸

Consists of 49,669 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Hassanein Waleed H
President & CEO, Director·Direct
Grant · Acquire
Stock Option (Right to Buy)Derivative
Shares+112.98K
Price$0.00
Total Value$0
Shares Owned After112.98K
Transaction DateJul 10, 2026
ExpiresJul 10, 2036
Footnotes ▸

The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.

Hassanein Waleed H
President & CEO, Director·Indirect · By the Waleed H. Hassanein Revocable Trust
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After345.01K
Footnotes ▸

Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended.

Post-Transaction Holdings

Hassanein Waleed H
SecuritySharesChange
Common Stock516.10K+49.67K (10.65%)
Stock Option (Right to Buy)112.98K+112.98K
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-10 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: TransMedics Group, Inc. (TMDX) CIK: 0001756262 --- Reporting Owner --- Name: Hassanein Waleed H CIK: 0001430466 Role: Director, Officer (President & CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-10 | Code: A (Grant or award) Shares: +49,669 | Price: $0.00 Shares Owned After: 171,093 | Ownership: D (Direct) Footnotes: [F1] Consists of 49,669 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-07-10 | Code: A (Grant or award) Shares: +112,984 | Price: $0.00 Exercisable: N/A | Expires: 2036-07-10 Shares Owned After: 112,984 | Ownership: D (Direct) Footnotes: [F3] The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) Footnotes: [F2] Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended. [Holding #2] Security: Common Stock Ownership: I (Indirect) Footnotes: [F2] Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended. --- Footnotes (Complete Index) --- F1: Consists of 49,669 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended. F3: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service. --- Signature --- /s/ By: /s/ Gerardo Hernandez, Attorney-in-Fact (2026-07-14)

keid analysis is for reference only and does not constitute investment advice.